Drug rash with eosinophilia and systemic symptoms (DRESS) is a rare, severe drug hypersensitivity syndrome characterized by fever, rash, hematologic abnormalities, and systemic involvement. The pathogenesis of DRESS is unclear, but it is thought that the offending drug induces an immune mediated hypersensitivity via defects in metabolism. Severe cases of DRESS often require aggressive treatment, but current pharmacologic treatment options are limited. We report a 66 year old female who presented with fever and rash three weeks after starting sulfasalazine treatment for rheumatoid arthritis. Investigation revealed diffuse lymphadenopathy, leukocytosis, eosinophilia, and hepatitis. She was diagnosed with DRESS, sulfasalazine was discontinued, and she was treated with methylprednisolone. Her condition deteriorated,